Network origin in Jason Barker first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
| Public Company | Biotechnology | 14 | |
| Public Company | Pharmaceuticals: Major | 9 | |
| Subsidiary | Biotechnology | 5 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Jason Barker via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | General Counsel Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
| UNITY BIOTECHNOLOGY, INC. | Biotechnology | Chairman Director/Board Member Director of Finance/CFO | |
| AMGEN INC. | Pharmaceuticals: Major | Public Communications Contact Corporate Officer/Principal Corporate Officer/Principal | |
| GILEAD SCIENCES, INC. | Biotechnology | Corporate Officer/Principal Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
| University of California, Berkeley | College/University | Undergraduate Degree Graduate Degree Doctorate Degree | |
| University of Maryland | College/University | Undergraduate Degree Undergraduate Degree Doctorate Degree | |
| ADVERUM BIOTECHNOLOGIES, INC. | Pharmaceuticals: Major | Chairman Director/Board Member | |
| Washington University School of Medicine | College/University | Doctorate Degree Corporate Officer/Principal | |
| INTERMUNE INC | Biotechnology | Director/Board Member Corporate Officer/Principal | |
| SAGIMET BIOSCIENCES INC. | Pharmaceuticals: Major | Director/Board Member Director of Finance/CFO | |
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| Stanford University | College/University | Undergraduate Degree Undergraduate Degree | |
| DAY ONE BIOPHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Onyx Pharmaceuticals, Inc.
 Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | Pharmaceuticals: Major | Corporate Officer/Principal Director of Finance/CFO | |
Jewish Hospital
 Jewish Hospital Hospital/Nursing ManagementHealth Services Part of Community Health Systems, Inc., Jewish Hospital is a hospital. The company is based in Cincinnati, OH. Jewish Hospital was acquired by Mercy Health Partners, Inc. (Pennsylvania), a NPO of Community Health Systems, Inc. from Jewish Foundation of Cincinnati on March 01, 2010 for $180 million. | Hospital/Nursing Management | Corporate Officer/Principal Corporate Officer/Principal | |
| ALPINE IMMUNE SCIENCES, INC. | Biotechnology | Director/Board Member President | |
| TURG POIN | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
California Life Sciences Association
 California Life Sciences Association Miscellaneous Commercial ServicesCommercial Services California Life Sciences Association (CLSA) is the largest and most influential life sciences advocacy and business leadership organization in California. The non-profit company is based in South San Francisco, CA, and has offices in other locations as well. The company works closely with industry, government, academia, and others to shape public policy, improve access to innovative technologies, and grow California's life sciences economy. CLSA serves biotechnology, pharmaceutical, medical device, and diagnostics companies, research universities and institutes, investors, and service providers throughout the state. Mike Guerra has been the CEO of the company since 2019. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
| REGENERON PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
California Biomedical Innovation Alliance
 California Biomedical Innovation Alliance BiotechnologyHealth Technology California Biomedical Innovation Alliance provides biomedical advocacy and community services. The private company is based in South San Francisco, CA and has subsidiaries in United States. The CEO of the company is Sara Radcliffe. | Biotechnology | Director/Board Member Director/Board Member | |
ALX Oncology, Inc.
 ALX Oncology, Inc. Pharmaceuticals: MajorHealth Technology Part of ALX Oncology Holdings, Inc., ALX Oncology, Inc. operates as a clinical-stage immuno-oncology company which develops therapies for cancers. The company is based in Burlingame, CA. The CEO of the company is Jaume Pons. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Ysios Capital Partners SGEIC SA
 Ysios Capital Partners SGEIC SA Investment ManagersFinance Ysios Capital Partners SGEIC SA (Ysios Capital) is a venture capital firm founded in 2007 by Joël Jean Pierre Jean-Mairet, Julia Salaverría Monfort and Josep Lluís Sanfeliu Benet. The firm is headquartered in San Sabastian, Spain with additional office in Barcelona. | Investment Managers | Private Equity Investor Private Equity Investor | |
OrbiMed Advisors Private Equity
 OrbiMed Advisors Private Equity Investment ManagersFinance OrbiMed Advisors Private Equity (OrbiMed Advisors Private Equity) is a private equity and venture capital subsidiary of Orbimed Advisors LLC founded in 1993 by Samuel D. Isaly. The firm is headquartered in New York and it has additional offices in San Francisco, Mumbai, Shanghai, Herzliya, Hong Kong and London. | Investment Managers | Private Equity Investor Private Equity Investor | |
Aragon Pharmaceuticals, Inc.
 Aragon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Aragon Pharmaceuticals, Inc. develops biopharmaceutical products, It offers a pipeline of new anti-endocrine therapies targeting the biology of hormone resistant cancers. The company was founded by Charles L. Sawyers and Michael Jung on May 1, 2009 and is headquartered in San Diego, CA. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Director/Board Member | |
| INFINITY PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
KAI Pharmaceuticals, Inc.
 KAI Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology KAI Pharmaceuticals, Inc. discovers and develops biopharmaceutical drugs. It is a multiple, novel clinical-stage programs in the areas of cardiovascular, renal, and pain. The company was founded in 2002 and is headquartered in South San Francisco, CA. | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal | |
| Washington University in St. Louis | College/University | Corporate Officer/Principal Corporate Officer/Principal | |
| THIRD HARMONIC BIO, INC. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer | |
| Yale University | College/University | Doctorate Degree Doctorate Degree | |
| University of California, Los Angeles | College/University | Undergraduate Degree Corporate Officer/Principal | |
Amgen Europe BV
 Amgen Europe BV Medical DistributorsDistribution Services Part of Amgen, Inc., Amgen Europe BV wholesales pharmaceutical products. The company is based in Breda, Netherlands. | Medical Distributors | Corporate Officer/Principal | |
| ANACOR PHARMACEUTICALS INC | Pharmaceuticals: Major | Director/Board Member | |
| Anderson School of Management | College/University | Masters Business Admin | |
| INTUITIVE SURGICAL, INC. | Medical Specialties | Director/Board Member | |
| KYTHERA BIOPHARMACEUTICALS INC | Pharmaceuticals: Major | Founder | |
| AFFYMAX, INC. | Biotechnology | Director/Board Member | |
Dompe Biotec SpA
 Dompe Biotec SpA Pharmaceuticals: MajorHealth Technology Dompe Biotec SpA (Dompé Biotec SpA) provides biotechnological drugs. Its products are used for the treatment of haematology, infectious diseases, nephrology, oncology, transfusion units and neuro-oncology. The company was founded in 1988 and is headquartered in Milan, Italy | Pharmaceuticals: Major | Director/Board Member | |
| SIENNA BIOPHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chairman | |
| University of Gothenburg | College/University | Doctorate Degree | |
| SPARK THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
| OCERA THERAPEUTICS INC | Pharmaceuticals: Major | Director/Board Member | |
Prothena Biosciences, Inc.
 Prothena Biosciences, Inc. BiotechnologyHealth Technology Part of Prothena Corp. Plc, Prothena Biosciences, Inc. is a company that specializes in the biology of misfolded proteins. The company is based in South San Francisco, CA. The company has over 3 decades of expertise in this field and offer a range of services including science, pipeline, clinical trial information, and more. | Biotechnology | Chairman | |
| PROTHENA CORPORATION PLC | Biotechnology | Director/Board Member | |
Schwartz Pharma AG
 Schwartz Pharma AG Pharmaceuticals: MajorHealth Technology Schwartz Pharma AG is a German company. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer |
Statistics
International
| United States | 42 |
| Ireland | 3 |
| Switzerland | 2 |
| Spain | 2 |
| Netherlands | 2 |
Sectoral
| Health Technology | 37 |
| Consumer Services | 10 |
| Finance | 3 |
| Health Services | 2 |
| Commercial Services | 2 |
Operational
| Director/Board Member | 229 |
| Corporate Officer/Principal | 84 |
| Independent Dir/Board Member | 80 |
| Chairman | 37 |
| Chief Tech/Sci/R&D Officer | 34 |
Most connected contacts
| Insiders | |
|---|---|
| Paul Sekhri | 62 |
| Stephen P. Squinto | 40 |
| Louis Lange | 35 |
| Clarence Machado | 30 |
| Robert J. Adelman | 25 |
| Herm Rosenman | 21 |
| Lars Ekman | 21 |
| Keith Leonard | 20 |
| Peter G. Milner | 18 |
| Kristen Hege | 17 |
| Rekha Hemrajani | 17 |
| David W. Beier | 16 |
| Antoni Ribas | 15 |
| Natalie Holles | 13 |
| William Grossman | 13 |
- Stock Market
- Insiders
- Jason Barker
- Company connections